Analysis of blood markers for early colorectal cancer diagnosis

BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs are based on fecal occult blood testing and colonoscopy. Our objective was to find a model based on the determination of blood biomarkers tha...

Full description

Saved in:
Bibliographic Details
Published inJournal of gastrointestinal oncology Vol. 13; no. 5; pp. 2259 - 2268
Main Authors Bayo Calero, Juan, Castaño López, Miguel Angel, Casado Monge, Pedro Germán, Díaz Portillo, Jacobo, Bejarano García, Ana, Navarro Roldán, Francisco
Format Journal Article
LanguageEnglish
Published AME Publishing Company 01.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs are based on fecal occult blood testing and colonoscopy. Our objective was to find a model based on the determination of blood biomarkers that was efficacious enough to become part of the early diagnosis of CRC. MethodsIn a total of 221 patients who underwent a colonoscopy, two types of markers were identified (I) classic: carcinoembryonic antigen (CEA), CA19.9, α-fetoprotein, CA125, CA72.4, and ferritin; and (II) experimental: neutrophil gelatinase-associated lipocalin (NGAL), estimated glomerular filtration rate (EGFR), 8-hydroxydeoxyguanosine (8OHdG), calprotectin, and cysteine-rich 61 (Cyr61). We divided the patients into four groups according to colonoscopy results: a control group (n=83) with normal colonoscopy, a polyp group (n=56), a CRC group (n=45), and an inflammatory disease group (n=37). We built an algorithm based on multivariate logistic regression analysis. ResultsA total of 51.6% were males, and the median age was 63 years. We designed an algorithm based on the combination of several markers that discriminated CRC patients from the rest of the patients with a performance of 94%, a sensitivity of 95.6%, and a specificity of 80.6%. Discriminating by sex also resulted in two powerful algorithms, although it performed better in males (97% vs. 91%). ConclusionsOur study has devised a predictive model with high efficacy based on the determination of several biomarkers. We think that it could be incorporated into the set of methods used in CRC screening.
AbstractList BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs are based on fecal occult blood testing and colonoscopy. Our objective was to find a model based on the determination of blood biomarkers that was efficacious enough to become part of the early diagnosis of CRC. MethodsIn a total of 221 patients who underwent a colonoscopy, two types of markers were identified (I) classic: carcinoembryonic antigen (CEA), CA19.9, α-fetoprotein, CA125, CA72.4, and ferritin; and (II) experimental: neutrophil gelatinase-associated lipocalin (NGAL), estimated glomerular filtration rate (EGFR), 8-hydroxydeoxyguanosine (8OHdG), calprotectin, and cysteine-rich 61 (Cyr61). We divided the patients into four groups according to colonoscopy results: a control group (n=83) with normal colonoscopy, a polyp group (n=56), a CRC group (n=45), and an inflammatory disease group (n=37). We built an algorithm based on multivariate logistic regression analysis. ResultsA total of 51.6% were males, and the median age was 63 years. We designed an algorithm based on the combination of several markers that discriminated CRC patients from the rest of the patients with a performance of 94%, a sensitivity of 95.6%, and a specificity of 80.6%. Discriminating by sex also resulted in two powerful algorithms, although it performed better in males (97% vs. 91%). ConclusionsOur study has devised a predictive model with high efficacy based on the determination of several biomarkers. We think that it could be incorporated into the set of methods used in CRC screening.
Author Navarro Roldán, Francisco
Bayo Calero, Juan
Casado Monge, Pedro Germán
Castaño López, Miguel Angel
Díaz Portillo, Jacobo
Bejarano García, Ana
Author_xml – sequence: 1
  givenname: Juan
  surname: Bayo Calero
  fullname: Bayo Calero, Juan
– sequence: 2
  givenname: Miguel Angel
  surname: Castaño López
  fullname: Castaño López, Miguel Angel
– sequence: 3
  givenname: Pedro Germán
  surname: Casado Monge
  fullname: Casado Monge, Pedro Germán
– sequence: 4
  givenname: Jacobo
  surname: Díaz Portillo
  fullname: Díaz Portillo, Jacobo
– sequence: 5
  givenname: Ana
  surname: Bejarano García
  fullname: Bejarano García, Ana
– sequence: 6
  givenname: Francisco
  surname: Navarro Roldán
  fullname: Navarro Roldán, Francisco
BookMark eNpVkE1LAzEQhoNUsNae_AM5CrKaj02yuSil-AUFLwreQprM1q3ppiZbof_eoEVwLvPCvPPM8J6iUR97QOickitGCVfX61WsGK1UrY7QmDGqK6n026hooppKNpqeoGnOa1Kq1oIINka3s96Gfe4yji1ehhg93tj0ASnjNiYMNoU9djHEBG6wATvbO0jYd3bVx7J2ho5bGzJMD32CXu_vXuaP1eL54Wk-W1SOi2aotBDOE8mkr6UXUmgOxLOlsgRs46kVnkvOoVHKclE76mptSa1800LrQQGfoJtf7na33IB30A_JBrNNXXl3b6LtzP9J372bVfwyWkpCGlYAFwdAip87yIPZdNlBCLaHuMuGKa5qKWpKi_Xy1-pSzDlB-3eGEvMTtSlRF2VK1Pwbl0J00g
CitedBy_id crossref_primary_10_1007_s10238_023_01260_5
crossref_primary_10_3390_cancers15112984
ContentType Journal Article
Copyright 2022 Journal of Gastrointestinal Oncology. All rights reserved. 2022 Journal of Gastrointestinal Oncology.
Copyright_xml – notice: 2022 Journal of Gastrointestinal Oncology. All rights reserved. 2022 Journal of Gastrointestinal Oncology.
DBID AAYXX
CITATION
7X8
5PM
DOI 10.21037/jgo-21-747
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 2219-679X
EndPage 2268
ExternalDocumentID 10_21037_jgo_21_747
GroupedDBID 04C
AAWTL
AAYXX
ADBBV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BMSDO
CITATION
DIK
GX1
HYE
M~E
OK1
RNS
RPM
7X8
5PM
ID FETCH-LOGICAL-c358t-955cd0626d46d56593e0d2b7a0ea8d1a5d3633e877a354c1c49a047d8fefde7e3
IEDL.DBID RPM
ISSN 2078-6891
IngestDate Fri Sep 01 02:39:38 EDT 2023
Fri Aug 16 21:37:21 EDT 2024
Fri Aug 23 02:53:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 5
Language English
License Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c358t-955cd0626d46d56593e0d2b7a0ea8d1a5d3633e877a354c1c49a047d8fefde7e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID: 0000-0002-6114-4222.
Contributions: (I) Conception and design: J Bayo Calero; (II) Administrative support: J Bayo Calero; (III) Provision of study materials or patients: PG Casado Monge, A Bejarano García; (IV) Collection and assembly of data: MA Castaño López, F Navarro Roldán; (V) Data analysis and interpretation: J Díaz Portillo; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660082/
PQID 2737465411
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9660082
proquest_miscellaneous_2737465411
crossref_primary_10_21037_jgo_21_747
PublicationCentury 2000
PublicationDate 2022-10-00
20221001
PublicationDateYYYYMMDD 2022-10-01
PublicationDate_xml – month: 10
  year: 2022
  text: 2022-10-00
PublicationDecade 2020
PublicationTitle Journal of gastrointestinal oncology
PublicationYear 2022
Publisher AME Publishing Company
Publisher_xml – name: AME Publishing Company
SSID ssj0000495052
Score 2.2936127
Snippet BackgroundColorectal cancer (CRC) is a very common tumor worldwide. Its mortality can be limited by early diagnosis through screening programs. These programs...
SourceID pubmedcentral
proquest
crossref
SourceType Open Access Repository
Aggregation Database
StartPage 2259
SubjectTerms Original
Title Analysis of blood markers for early colorectal cancer diagnosis
URI https://search.proquest.com/docview/2737465411
https://pubmed.ncbi.nlm.nih.gov/PMC9660082
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS8NAEB1aD-JF1CrWL1Yo3tYm2d1schIRtQgVDwq9hf2KVmwqbT34753dNNpevQVClvB2yLzJvnkD0HNaasU4oyJLNOXOCaqVEBSpBOfKlkma-d7h4WM6eOEPIzFqgWh6YYJo3-jxZfUxuazGb0Fb-Tkx_UYn1n8a3nhHSUxd_Ta0MUBXSvT3mvL64Wx-qBymP5pmeVz35SXBzOf9dUqTmEo_T2U1E_3Ry3Vx5Eq2uduB7SVNJNf16-xCy1V70LmusESefJMLEoSb4Y_4HmwOl-fjHbhqPEbItCRBk04mXn8zmxMkp8R5N2Pifar9dw7XN37PZ8TWervxfB9e7m6fbwZ0OSKBGiayBc2FMDbCosTy1CI3y5mLbKKlipzKbKyEZSljLpNSMcFNbHiuIi5tVrrSOunYAWxU08odAnFSs7y0UhpjvGOhVkoooZ3KeamSiHeh18BVfNZOGAVWEAHVAlHFqwJR7cJ5A2WBkeqPH1Tlpl_zAomS9O5tcdwFuYbx73re63r9DoZA8LxebvnRv588hq3Edy4EHd4JbCxmX-4U-cRCn0H7fhSfhSj6Aa3rz2k
link.rule.ids 230,315,730,783,787,888,27938,27939,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0BlQoXKB8VS6G4EuLm3SS24-SEEAJtC4t6gIpb5K_QBTaL9uMAv75jZwO7vbW3SFasRM_OvInfvAE4clpqxTijIks05c4JqpUQFKkE58qWSZr52uHeddq95T_uxN0SiKYWJoj2je63q6dBu-r_DtrK54HpNDqxzs_emXeUxNDVWYYPuF-jdC5Jf6hJr2_P5tvKYQCkaZbHdWVeEux8Hu6HNImp9B1V5mPRO8FclEfOxZuLDfjVPGktM3lsTye6bV7_MnH851f5BOszBkpO6-FNWHLVFmyfVph9D17IMQma0PCzfQs-9mZH79tw0tiXkGFJgtydDLy0ZzQmyHuJ80bJxFtg-08ozm_8choRW0v5-uMduL04vznr0ln3BWqYyCY0F8LYCPMdy1OLtC9nLrKJlipyKrOxEpaljLlMSsUEN7HhuYq4tFnpSuukY59hpRpWbheIk5rlpZXSGOPNELVSQgntVM5LlUS8BUcNDsVzbbJRYHIS4CoQLrwqEK4WfGswKnAT-JMNVbnhdFwgB5PeGC6OWyAXwHubz9toL44gJMFOewbB3n_feQir3ZveVXH1_fryC6wlvkAiyP32YWUymroDpC0T_TUs0j85a_Bv
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0VKiEuQPlQF0rrSoibd5PYjpNThYAVLSziUCTEJfJXYCmbXe3Hgf76jp0N7PbILVISK9GzM2_iN28AjpyWWjHOqMgSTblzgmolBEUqwbmyZZJmvna4d51e3PJfd-JuodVXEO0b3W9Xz4N21X8M2srRwHQanVjnpnfqHSUxdHVGtuyswEdcs1G2kKg_1cTXt2jzreUwCNI0y-O6Oi8Jlj5PD0OaxFT6riqL8eiNZC5LJBdiTncT7punraUmf9qzqW6bv_8ZOb7rdbZgY85EyUl9ySf44Kpt2DmpMAsfvJBjErSh4af7Nqz15lvwO_CjsTEhw5IE2TsZeInPeEKQ_xLnDZOJt8L2n1Ic3_hpNSa2lvT1J7tw2z3_fXpB510YqGEim9JcCGMjzHssTy3Sv5y5yCZaqsipzMZKWJYy5jIpFRPcxIbnKuLSZqUrrZOO7cFqNazcZyBOapaXVkpjjDdF1EoJJbRTOS9VEvEWHDVYFKPabKPAJCVAViBkeFQgZC343uBU4GLwOxyqcsPZpEAuJr1BXBy3QC4B-Dqet9NePoOwBFvtOQz7777zG6zdnHWLq5_Xlwewnvg6iaD6-wKr0_HMHSJ7meqvYZ7-A7yC8u8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Analysis+of+blood+markers+for+early+colorectal+cancer+diagnosis&rft.jtitle=Journal+of+gastrointestinal+oncology&rft.au=Bayo+Calero%2C+Juan&rft.au=Casta%C3%B1o+L%C3%B3pez%2C+Miguel+Angel&rft.au=Casado+Monge%2C+Pedro+Germ%C3%A1n&rft.au=D%C3%ADaz+Portillo%2C+Jacobo&rft.date=2022-10-01&rft.pub=AME+Publishing+Company&rft.issn=2078-6891&rft.eissn=2219-679X&rft.volume=13&rft.issue=5&rft.spage=2259&rft.epage=2268&rft_id=info:doi/10.21037%2Fjgo-21-747&rft.externalDBID=PMC9660082
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2078-6891&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2078-6891&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2078-6891&client=summon